Table 4. Neoplasms Found in the Study Population.
Patient Sex/Age, y | Reason for Intervention | Time to Intervention, d | Intervention | Histological Findings | Time to Secondary Intervention, d | Secondary Intervention |
---|---|---|---|---|---|---|
F/56 | Allocated intervention | 90 | Appendectomy | LAMN and pseudomyxoma peritonei | 156 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy |
M/47 | Allocated intervention | 120 | Appendectomy | LAMN | NA | Surveillance |
M/59 | Allocated intervention | 134 | Appendectomy | Sessile serrated adenoma | NA | Surveillance |
M/59 | Recurrent symptoms | 329 | Ileocecal resection | Adenocarcinoma of the appendix | 378 | Right hemicolectomy |
M/59 | Recurrent symptoms | 18 | Appendectomy | LAMN | 98 | Ileocecal resection |
M/61 | Recurrent symptoms | 330 | Appendectomy | Mucinous cystadenoma | NA | Surveillance |
M/55 | Recurrent symptoms | 189 | Appendectomy | Goblet cell carcinoid | 252 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy |
F/58 | MRI tumor suspicion | 199 | Appendectomy | Sessile serrated adenoma | NA | Surveillance |
F/53 | CT tumor suspicion | 171 | Chemotherapy | Cecal adenocarcinoma and sessile serrated appendiceal adenoma | 332 | Right hemicolectomy (palliative) |
M/61 | Recommended | 429 | Appendectomy | LAMN | NA | Surveillance |
F/41 | Recommended | 142 | Appendectomy | LAMN | NA | Surveillance |
Abbreviations: CT, computed tomography; LAMN, low-grade appendiceal mucinous neoplasm; MRI, magnetic resonance imaging; NA, not applicable.